Blog
>
News
>
Meet eo: the Future of Cannabis Care

Meet eo: the Future of Cannabis Care

People are suffering. Cannabis offers the potential of relief, but cannabis care today leaves much to be desired in the way of guidance, data, and consistency. eo is a digital therapeutic, telemedicine platform and clinical data source. We are on a mission to deliver the future of cannabis care through personalized, calendar-based care plans and ongoing clinical guidance delivered on an intuitive digital platform.

Learn More About EO's Products

Every EO product is clinician-designed and precisely dosed. Inhalers, gummies, tablets, tinctures, topicals, and beverage shots. They ship straight to your door, no dispensary needed.

Responsibly Made & Tested

  • ✓ 100% organic hemp, no synthetics
  • ✓ Produced at GMP-certified facilities
  • ✓ 3rd-party tested for accuracy/safety

Federally Legal

  • ✓ <0.3% hemp-derived THC
  • ✓ Farm Bill compliant
  • ✓ Ships to your door like any package

Expert Guidance Included

  • ✓ Ensure optimal dosing
  • ✓ Minimize side effects
  • ✓ Use safely and wisely
Explore


Meet eo:

People are suffering. Cannabis offers the potential of relief, but cannabis care today leaves much to be desired in the way of guidance, data, and consistency.

eo is a digital therapeutic, telemedicine platform and clinical data source. We are on a mission to deliver the future of cannabis care through personalized, calendar-based care plans and ongoing clinical guidance delivered on an intuitive digital platform.

Learn more


Meet the team:

Expert medical knowledge, complex data modeling, user experience optimization, and everything in between. On team eo, we each bring something different to the table, but all share one goal---relieving patient suffering at scale.

eo CEO and co-founder Sean Collins has long had an interest in the idea of state change. Sean is a seasoned developer of data-backed guidance platforms working to solve complex problems like this one. Our CXO and co-founder Dave Batista has grown multiple leading digital agencies and spearheaded user experience design efforts in financial services, and consumer products and brands. Also leading the team is cannabis advocate and patient, Jill Minkin, who joins eo as an advisor. Jill offers her extensive experience around organizational structure, team building, and investment strategy as well as her invaluable perspective as a cannabis patient herself.

Responsible for eo’s clinical guidance is Dr. Benjamin Caplan, our CMO. Dr. Caplan is a board-certified family physician and internationally recognized cannabis clinician, educator, and advocate. He founded Massachusetts’ premier medical cannabis clinic CED Clinic as well as the CED Foundation. Our Senior Data Modeler Kristen Parton is the woman behind the data model that makes eo what it is. Kristen is well-versed in Bayesian modeling, AI and decision network model design and has experience across biotech, financial, and medical industries.

On team eo, our unique backgrounds and strengths combine to enable us to fill the gaps in the patient experience by providing evidence-based care to those who need it.

To learn more about our team, click here.



These statements have not been evaluated by the Food and Drug Administration. This page is not intended to diagnose, mitigate, treat, cure, or prevent any disease.

Free Care Plans? Of Course.

Everyone deserves personalized, clinically responsible cannabis guidance. Tell us about your symptoms, get a plan from our clinician-led team, and message them anytime. Free, with up to 20% off the products in your plan.

Get a Free Care Plan
More
News
News

ASCO Annual Meeting 2026: Iterative Cannabis Care Plans

At the 2026 ASCO Annual Meeting, cannabinoid-based symptom management was recognized for its critical role in improving patient outcomes.

Read More
Read More
News

Cannabis Rescheduling: A Turning Point for Symptom Management in Healthcare

A major policy shift is reshaping how providers and payers approach symptom management. Here’s what cannabis rescheduling means for clinical care, reimbursement, and patient outcomes.

Read More
Read More
News

EO Care Appoints William Fleming and Kristi Savacool to Board of Directors

EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.

Read More
Read More